SIRT1 and posterior cortical atrophy: A novel therapeutic approach using the co-delivery of doxorubicin and miR-34a via micellar systems has been shown to synergistically downregulate SIRT1, suppress proliferation in androgen-independent PCa cells, and enhance the efficacy of chemotherapy [147].